OOIR: Observatory of International Research

Papers

(The H4-Index of Modern Pathology is 47. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City	368
A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression	348
Digital pathology and artificial intelligence in translational medicine and clinical practice	260
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19	248
SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers	205
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience	183
Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data	179
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia	151
Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel	148
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia	125
Development of a prognostic model for mortality in COVID-19 infection using machine learning	115
Validation of a digital pathology system including remote review during the COVID-19 pandemic	115
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer	107
Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists	101
Lung neuroendocrine neoplasms: recent progress and persistent challenges	99
Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19	93
Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)	85
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer	82
Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review	82
Quality control stress test for deep learning-based diagnostic model in digital pathology	81
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases	80
DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma	79
Counting mitoses: SI(ze) matters!	77
An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy	74
NTRK insights: best practices for pathologists	69

Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning	69
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer	69
Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)	68
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer	68
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases	65
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization	65
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles	62
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial	61
Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection	60
PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy	60
ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217	59
Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointesti	57
Integrating digital pathology into clinical practice	57
Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions	56
EWSR1/FUS–CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities	56
Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus	54
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification	50
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer	49
Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer	49
Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associated fetal demise	48
Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer	47
Liver biopsy findings in patients on immune checkpoint inhibitors	47